The Administration of 4-Hexylresorcinol Accelerates Orthodontic Tooth Movement and Increases the Expression Level of Bone Turnover Markers in Ovariectomized Rats

Surgical methods for accelerating orthodontic tooth movement are limited by possible damage to the tooth root and patient discomfort. 4-Hexylresorcinol (4HR) has been shown to increase bone remodeling and may potentially facilitate tooth movement. This study investigated the (1) effect of 4HR administration on osteoblast-like cells and (2) effect of 4HR administration on tooth movement in ovariectomized rats. Saos-2 cells were treated with either 4HR or solvent (control). Protein expression levels were investigated 2, 8, and 24 h after treatment. Thirty ovariectomized Sprague-Dawley rats were divided into two experimental groups (A and B) and one control group. After installation of an orthodontic tooth movement device, groups A and B received subcutaneous weekly injections of 4HR (1.28 and 128 mg/kg). Micro-computerized tomography and histological analyses were performed after 2 weeks of tooth movement. The application of 4HR elevated expression of osteogenic markers in Saos-2 cells. Movement of the first molars was significantly greater in rats administered 4HR. Furthermore, the expression of bone morphogenic protein-2, receptor activator of nuclear factor kappa-B ligand, osteocalcin, and tartrate-resistant acid phosphatase were increased after 4HR administration. 4HR application demonstrated increased expression of osteogenic markers in Saos-2 cells and accelerated orthodontic tooth movement in rats.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

International journal of molecular sciences - 21(2020), 4 vom: 24. Feb.

Sprache:

Englisch

Beteiligte Personen:

Choi, Kwang-Hyo [VerfasserIn]
Kim, Dae-Won [VerfasserIn]
Lee, Suk Keun [VerfasserIn]
Kim, Seong-Gon [VerfasserIn]
Kim, Tae-Woo [VerfasserIn]

Links:

Volltext

Themen:

104982-03-8
106441-73-0
4-hexylresorcinol
Animal model
Biomarkers
Bone morphogenic protein
Hexylresorcinol
Journal Article
Nuclear factor kappa-B ligand
Orthodontic
Osteocalcin
Osteopontin
Ovariectomy
R9QTB5E82N
Tooth movement
Transforming Growth Factor beta1

Anmerkungen:

Date Completed 23.11.2020

Date Revised 23.11.2020

published: Electronic

Citation Status MEDLINE

doi:

10.3390/ijms21041526

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306946149